CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 85 filers reported holding CHINOOK THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $137,937 | -98.9% | 3,590 | -99.3% | 0.00% | -100.0% |
Q1 2023 | $12,258,388 | +52.5% | 529,520 | +72.6% | 0.00% | 0.0% |
Q4 2022 | $8,038,422 | +24.2% | 306,810 | -6.8% | 0.00% | 0.0% |
Q3 2022 | $6,473,000 | +4.3% | 329,239 | -7.2% | 0.00% | 0.0% |
Q2 2022 | $6,206,000 | -33.4% | 354,834 | -37.7% | 0.00% | 0.0% |
Q1 2022 | $9,312,000 | -43.8% | 569,173 | -43.9% | 0.00% | 0.0% |
Q4 2021 | $16,561,000 | +27.8% | 1,015,381 | +0.0% | 0.00% | 0.0% |
Q3 2021 | $12,954,000 | +17.8% | 1,015,241 | +30.4% | 0.00% | 0.0% |
Q2 2021 | $10,993,000 | -18.3% | 778,522 | -10.1% | 0.00% | 0.0% |
Q1 2021 | $13,455,000 | -2.0% | 865,822 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $13,732,000 | – | 865,822 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Parallel Advisors, LLC | 5 | $0 | 0.00% |